Arkema S.A. (OTCMKTS:ARKAY - Get Free Report) shares hit a new 52-week low during trading on Tuesday . The stock traded as low as $75.63 and last traded at $75.73, with a volume of 34532 shares traded. The stock had previously closed at $77.40.
Analyst Ratings Changes
Separately, Berenberg Bank upgraded shares of Arkema from a "hold" rating to a "strong-buy" rating in a research note on Thursday, October 31st.
Get Our Latest Report on Arkema
Arkema Stock Performance
The firm has a market cap of $5.76 billion, a price-to-earnings ratio of 15.48, a price-to-earnings-growth ratio of 0.47 and a beta of 1.23. The company has a current ratio of 2.11, a quick ratio of 1.54 and a debt-to-equity ratio of 0.48. The stock's 50 day moving average is $84.77 and its 200 day moving average is $88.89.
Arkema (OTCMKTS:ARKAY - Get Free Report) last announced its earnings results on Wednesday, November 6th. The basic materials company reported $2.45 earnings per share (EPS) for the quarter. The firm had revenue of $2.63 billion for the quarter. Arkema had a net margin of 3.82% and a return on equity of 8.04%. Analysts anticipate that Arkema S.A. will post 9.13 earnings per share for the current year.
Arkema Company Profile
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.